Resveratrol enhances the antimicrobial effect of polymyxin B on Klebsiella pneumoniae and Escherichia coli isolates with polymyxin B resistance

Abstract Background Multidrug resistant (MDR) Gram-negative bacterial infections are a serious threat to human health due to the lack of effective treatments. In this study, we selected 50 Gram-negative bacterial strains, including 26 strains of Klebsiella pneumoniae and 24 strains of Escherichia co...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Li Liu, Jingyi Yu, Xiaofei Shen, Xingwei Cao, Qing Zhan, Yinjuan Guo, Fangyou Yu
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BMC 2020-10-01
Sarja:BMC Microbiology
Aiheet:
Polymyxin B
Resveratrol
Combination therapy
Multidrug resistance (MDR)
Linkit:http://link.springer.com/article/10.1186/s12866-020-01995-1
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia